Media

Presentations

Corporate Presentation

Download Presentation

Videos

Interview with OKYO CEO Robert Dempsey and Steve Darling from Proactive Discussing FDA Type C Meeting (Jan 2026)

Interview with CEO Gary Jacob and Steve Darling from Proactive to share the top-line results from the recently completed Phase 2 trial . (July 2025)

OKYO CEO Gary Jacob talks to RedChip about the recent initiation of the Phase 2 trial for Neuropathic Corneal Pain (NCP) (Nov 2024)

Interview with OKYO’s New CEO Robert Dempsey and Steve Darling from Proactive (Jan 2026)

Interview with OKYO Pharma CEO, Gary Jacob following the announcement of the early closure of NCP Trial to gain access to efficacy data. (April 2025)